Importantly, the inhibition of the PEPCK-M pathway was selective as there was no effect on the entry of glutamine label, or its incorporation into glutamate or malate (Fig. 4A), consistent with data on PEPCK-M loss-of-function and gain-of-function cervix carcinoma cells (HeLa) [11]. Here, PCK2 is linked to cervical carcinoma.